Biotech News

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Rapid Micro Biosystems (RPID)Rapid Micro Biosystems2026-01-13 21:15 ESTEarnings

Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% compared to the prior-year period. Received record multi-system order in the fourth quarter from an existing Top 20 global biopharma customer to automate global manufacturing

Rapid Micro Biosystems

Automated Microbial Quality Control Rapid Micro Biosystems provides automation systems used to test biologics, vaccines, cell and gene therapies, sterile injectables, and other healthcare products for microbial contamination. Growth Direct Platform The Growth Direct system replaces manual microbial quality-control workflows with...

Recent company news

RPIDRapid Micro Biosystems2026-10-20 20:25 EST

Stock data

Close: 0.80 USD
Market cap: 97.65M USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Related news

Rapid Micro Biosystems Reports Third Quarter 2025 Financial Results; Announces Record Multi-System Customer Order and Raises Full-Year Revenue and System Placement Guidance

Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Rapid Micro Biosystems

Recent company news

Rapid Micro Biosystems to Participate at the PDA Pharmaceutical Microbiology Conference 2026

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

Stock data